例如:"lncRNA", "apoptosis", "WRKY"

Wnt and Neuregulin1/ErbB signalling extends 3D culture of hormone responsive mammary organoids.

Nat Commun. 2016 Oct 26;7:13207
Thierry Jardé 1 , Bethan Lloyd-Lewis 2 , Mairian Thomas 3 , Howard Kendrick 4 , Lorenzo Melchor 5 , Lauriane Bougaret 3 , Peter D Watson 3 , Kenneth Ewan 3 , Matthew J Smalley 4 , Trevor C Dale 3
Thierry Jardé 1 , Bethan Lloyd-Lewis 2 , Mairian Thomas 3 , Howard Kendrick 4 , Lorenzo Melchor 5 , Lauriane Bougaret 3 , Peter D Watson 3 , Kenneth Ewan 3 , Matthew J Smalley 4 , Trevor C Dale 3
+ et al

[No authors listed]

Author information
  • 1 Centre for Cancer Research, Hudson Institute of Medical Research, Clayton, Victoria 3168, Australia.
  • 2 Department of Pathology, University of Cambridge, Cambridge CB2 1QP, UK.
  • 3 Cardiff School of Biosciences, Cardiff University, Cardiff CF10 3AX, UK.
  • 4 European Cancer Stem Cell Research Institute, Cardiff School of Biosciences, Cardiff University, Cardiff CF24 4HQ, UK.
  • 5 Division of Breast Cancer Research, Breast Cancer Now, Institute of Cancer Research, London SW3 6JB, UK.

摘要


The development of in vitro culture systems quantitatively and qualitatively recapitulating normal breast biology is key to the understanding of mammary gland biology. Current three-dimensional mammary culture systems have not demonstrated concurrent proliferation and functional differentiation ex vivo in any system for longer than 2 weeks. Here, we identify conditions including Neuregulin1 and R-spondin 1, allowing maintenance and expansion of mammary organoids for 2.5 months in culture. The organoids comprise distinct basal and luminal compartments complete with functional steroid receptors and stem/progenitor cells able to reconstitute a complete mammary gland in vivo. Alternative conditions are also described that promote enrichment of basal cells organized into multiple layers surrounding a keratinous core, reminiscent of structures observed in MMTV-Wnt1 tumours. These conditions comprise a unique tool that should further understanding of normal mammary gland development, the molecular mechanism of hormone action and signalling events whose deregulation leads to breast tumourigenesis.